Companies · Other Health Care

Pursuit Vascular, Inc.

MAPLE GROVE · Other Health Care

Diligence memoA one-page analyst read on Pursuit Vascular, Inc. — recommendation, valuation, rhythm, risks.
$12.3M
Total raised · real
6
Rounds
0.4×
Latest step-up
Top 23%
Sector rank · raised
Series A
Latest stage · inferred · Wed Jul 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Pursuit Vascular, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.35× the median modeled value of Series A Other Health Care companies in 2016–2018 (157 peers) — value vs value, same stage and era.
Dormant
  • Last raise 9.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Pursuit Vascular, Inc. is one of 5376 Other Health Care companies tracked from MAPLE GROVE. By capital raised it ranks in the upper tier (ahead of 78% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MPre-Seed · 2012-02-16 Raised $581K (real) Modeled valuation $18M (est)$581K$18MPre-Seed2012Seed · 2012-08-13 Raised $1.3M (real) Modeled valuation $33M (est)$1.3M$33MSeed2012Seed · 2014-02-04 Raised $1.6M (real) Modeled valuation $39M (est)$1.6M$39MSeed2014Seed · 2015-01-23 Raised $1.6M (real) Modeled valuation $40M (est)$1.6M$40MSeed2015Series A · 2015-03-20 Raised $5.1M (real) Modeled valuation $103M (est)$5.1M$103MSeries A2015Series A · 2016-07-27 Raised $2.1M (real) Modeled valuation $42M (est)$2.1M$42MSeries A2016+$1.3M+$1.6M+$1.6M+$5.1M+$2.1MCumulative $12M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$581K · 2012
Seed$1.3M · 2012
Seed extension$1.6M · 2014
Seed extension$1.6M · 2015
Series A$5.1M · 2015
Series A extension$2.1M · 2016

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$42.1M
Base estimate est.
$2.7M
Conservative case
$228.9M
Upside case
$9.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $17.9M · 2012-02-162012Seed · modeled $33.3M · 2012-08-13Seed · modeled $38.8M · 2014-02-04Seed · modeled $39.9M · 2015-01-23Series A · modeled $103.1M · 2015-03-20Series A · modeled $42.1M · 2016-07-272016
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
9.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
11 mo
Avg between rounds
$2.8M/yr
Capital velocity
14.4 yr
On record since
2012
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 5.1× above median
This company$12.3M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.4× of median
This company$2.1M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 1.9× above median
This company$42.1M
Sector median$22.1M

Raised more than 78% of sector peers (real $). Modeled value above 64% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #134 of 157.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)HemoSonics, LLC · Series A Raised $24.9M · modeled $302.7M (est)Airxpanders Inc · Series A Raised $60.0M · modeled $300.5M (est)Mercator Medsystems Inc · Series A Raised $20.5M · modeled $289.2M (est)Simple Contacts Inc. · Series A Raised $24.1M · modeled $285.5M (est)AVG Holdings, Inc. · Series A Raised $14.0M · modeled $282.5M (est)Avia Holdings, Llc · Series A Raised $27.9M · modeled $272.7M (est)Traditions at Rivertown Park, LLC · Series A Raised $13.5M · modeled $272.4M (est)Access Integrated Healthcare, LLC · Series A Raised $13.2M · modeled $265.8M (est)Gauss Surgical, Inc. · Series A Raised $20.5M · modeled $254.2M (est)4WEB, Inc. · Series A Raised $12.5M · modeled $252.2M (est)Iantech, Inc. · Series A Raised $12.2M · modeled $246.7M (est)AbsoluteCARE, Inc. · Series A Raised $25.7M · modeled $242.6M (est)Pursuit Vascular, Inc. (this company) Raised $12.3M · modeled $42.1M (est)Pursuit Vascular, Inc.
CompanyStageRaised · realValue · estvs peer med.
HemoSonics, LLCSeries A$24.9M$302.7M2.50×
Airxpanders IncSeries A$60.0M$300.5M2.48×
Mercator Medsystems IncSeries A$20.5M$289.2M2.39×
Simple Contacts Inc.Series A$24.1M$285.5M2.36×
AVG Holdings, Inc.Series A$14.0M$282.5M2.33×
Avia Holdings, LlcSeries A$27.9M$272.7M2.25×
Traditions at Rivertown Park, LLCSeries A$13.5M$272.4M2.25×
Access Integrated Healthcare, LLCSeries A$13.2M$265.8M2.20×
Gauss Surgical, Inc.Series A$20.5M$254.2M2.10×
4WEB, Inc.Series A$12.5M$252.2M2.08×
Iantech, Inc.Series A$12.2M$246.7M2.04×
AbsoluteCARE, Inc.Series A$25.7M$242.6M2.00×
Pursuit Vascular, Inc. this companySeries A$12.3M$42.1M0.35×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$581K2012-02-16$3.2M$17.9M90%
Seed$1.3M2012-08-13$6.7M$33.3M90%
Seed$1.6M2014-02-04$7.8M$38.8M90%
Seed$1.6M2015-01-23$8.1M$39.9M90%
Series A$5.1M2015-03-20$23.2M$103.1M90%
Series A$2.1M2016-07-27$9.5M$42.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$581K2012-02-16
    • First recorded raise — entered as Pre-Seed.
  2. Seed$1.3M2012-08-13
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 2.3× larger than the prior — scaling up.
  3. Seed$1.6M2014-02-04
    • Raised 18 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  4. Seed$1.6M2015-01-23
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  5. Series A$5.1M2015-03-20
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 3.2× larger than the prior — scaling up.
  6. Series A$2.1M2016-07-27
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round 2.5× smaller than the prior — bridge or down round.
Intelligence
2017 ~Q2
Modeled next raise · ~11mo cadence
$2.1M
Modeled next size est.range $2.1M$3.3M
0.4×
Last step-up
$2.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Kevin Roche5 other2015-03
Dale Spencer2 other2014-02
Jack Helms1 other2014-02
Robert Ziebol1 other2012-02
Doug Killion2012-02
Robert Weinmann, M.D.2012-08
Roy Martin, Jr.2014-02
Registry & provenance

Pursuit Vascular, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1543609
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Tactile Systems Technology IncOther Health CareSeries A$23.4M$209.9Mnetwork1 shared operator · same sector · same stage
Emerging Therapy Solutions, Inc.Other Health CareSeries A$24.3M$26.8Mnetwork1 shared operator · same sector · same stage
Care Cam Innovations, LLCOther Health CareSeries A$12.4M$48.4Msame sector · same stage
ActX, Inc.Other Health CareSeries A$12.1M$50.7Msame sector · same stage
NuOrtho Surgical, IncOther Health CareSeries A$12.0M$42.5Msame sector · same stage
Blockade Medical, LLCOther Health CareSeries A$12.7M$47.8Msame sector · same stage
Summit Behavioral Healthcare, LLCOther Health CareSeries A$11.7M$40.4Msame sector · same stage
Facet Solutions IncOther Health CareSeries A$13.0M$42.8Msame sector · same stage
Frequently asked
How much funding has Pursuit Vascular, Inc. raised?
Pursuit Vascular, Inc. has raised approximately $12.3M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is Pursuit Vascular, Inc.'s estimated valuation?
Provath's modeled valuation for Pursuit Vascular, Inc. is approximately $42.1M (modeled range $2.7M–$228.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Pursuit Vascular, Inc. at?
Pursuit Vascular, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Wed Jul 27.
What does Pursuit Vascular, Inc. do and where is it based?
Pursuit Vascular, Inc. operates in the Other Health Care sector, based in MAPLE GROVE.
Explore related

See where Pursuit Vascular, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Pursuit Vascular, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.